AstraZeneca Pharma India Ltd has received approval from India's drug regulator to import and sell sodium zirconium cyclosilicate powder for treating hyperkalaemia in adults. This clearance enables the launch of Lokelma in India, contingent on obtaining related statutory approvals.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/dKLQ2F9
via IFTTT
-
Kotak Alternate Asset Managers has announced a Rs 1,445 crore investment in the acquisition of Viatris' active pharmaceutical ingredient...
-
Vaccine manufacturer Serum Institute of India (SSI) has filed a challenge to the Supreme Court against a 2016 amendment to the Income Tax Ac...
-
Acquista ********, Ossicodone, Ketamina, Ozempic (WhatsApp: +31616337954) I nostri prodotti hanno una purezza del 98-99%. E-mail di cont...
Search This Blog
Powered by Blogger.
Blog Archive
-
▼
2025
(206)
-
▼
March
(65)
- View: Will Trump's tariffs lift the veil on India'...
- Ankura Hospitals secures Rs 165 cr funding from ADB
- KKR in talks to acquire US dental labs chain Leixir
- From AI to Telemedicine: Digital skills every heal...
- Eli Lilly working on a heart drug that may benefit...
- 47 drugs found 'not of standard quality' in February
- Essential medicines will cost you a bit more from ...
- Kedaara, TA Associates vie for minority stake in S...
- Donor aid cuts may undo years of progress in comba...
- Delhi HC asks Natco Pharma to pause Risdiplam laun...
- Open to tie-ups in India for selling Mounjaro: Eli...
- Eli Lilly's goal is to reach everyone who needs ob...
- India develops its first indigenous MRI machine, t...
- Meghalaya’s Gnanamma Healthcare Centre transitions...
- Delhi HC rejects Roche's plea to block Natco Pharm...
- Heartening news: Device made in India to help tran...
- ₹14,000 per month weight-loss shot is here to cash...
- Bharat Biotech invests Rs 600 cr to expand into ce...
- Entero Healthcare launches HealthEdge programme fo...
- Eli Lilly launches weight-loss drug Mounjaro in In...
- India has a chance to lead in health space amid Gl...
- Impose safeguard duties on medical devices: AiMeD
- AI, teleconsultation, modern tech being used in tr...
- Health expenditure now at 1.84 pc of GDP, moving s...
- Zydus Lifesciences gets USFDA nod to produce prost...
- India weighs lower tariffs for US medical devices ...
- Gene therapy for blood cancer shows 73 per cent re...
- AIIMS critically short of staff amid land & budget...
- Sun Pharma, Zydus recall products in US: USFDA report
- Skin cream, nasal spray, and... blindness? AIIMS d...
- Struggling with dry eyes? Haldi's power-packed com...
- China’s biotech is redrawing the global pharma map...
- Parliamentary panel flags brain drain from health ...
- Parl panel on health: Cos scared to set up units d...
- Dr. Reddy’s recalls mislabelled Levetiracetam inje...
- Indian generic drugs linked to deaths in US? Trade...
- Global buyout funds line up for AGS Health
- New affordable diabetes drug Empagliflozin launche...
- Zydus eyes major stake in French medtech Amplitude...
- India, vaccine superpower; manufactures 60% of glo...
- Zydus Lifesciences to buy 86% stake in French medi...
- ET Q&A: All our products are legitimate, sold unde...
- India's Syngene International acquires first US bi...
- Zydus Lifesciences gets USFDA nod to market generi...
- Sun Pharmaceuticals to acquire Checkpoint Therapeu...
- Keep tobacco and alcohol ads and their proxies off...
- USFDA pulls up Granules India for lapses in mainta...
- Protecting your heart and managing diabetes: The p...
- Indian Pharmaceutical Alliance calls for zero impo...
- Registration for Ayushman Bharat to start after Ma...
- Apollo Health picks up controlling stake in Luckno...
- AstraZeneca gets nod to import, sell hyperkalaemia...
- Lasik surgery in 10 seconds? This AI-powered tech ...
- Clinical research entities asked to register by Ap...
- Aurobindo unit terminates pact with Singapore firm...
- India set to introduce list of OTC drugs this month
- Senores Pharma to acquire 14 ANDAs from Dr Reddy's...
- Zydus to develop combination vaccine for shigellos...
- Diabetes and obesity: The dangerous duo you need t...
- AstraZeneca Pharma India gets CDSCO approval to im...
- Sun Pharma aims to launch anti-obesity and type 2 ...
- Glenmark acquires Acetylcysteine injection, launch...
- Glenmark recalls 15 lakh bottles of ADHD medicatio...
- Reciprocal tariffs may make Indian generic drugs c...
- Our healthcare, education systems being plagued by...
-
▼
March
(65)
Recent Posts
Unordered List
Theme Support
-
Text Widget
Design by FlexiThemes | Blogger Theme by Lasantha - PremiumBloggerTemplates.com | Best Gadgets | Distributed By Gooyaabi Templates
0 comments:
Post a Comment